The Experts below are selected from a list of 123 Experts worldwide ranked by ideXlab platform
Maryam Tabrizian - One of the best experts on this subject based on the ideXlab platform.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4'-methylenebis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain exte
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, J. S. R. del Barrio, José Parra, Roi Rath, R. Vargas-coronado, Elizabeth Phelps, Jorge Cervantes, Alejandro Garcia, Yahye Merhi, Maryam TabrizianAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4'-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
L. Chan-Chan - One of the best experts on this subject based on the ideXlab platform.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain extend
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, José Parra, Roi Rath, R. Vargas-coronado, José M. Cervantes-uc, Juan V. Cauich-rodríguez, Ea Phelps, Andrés J. García, J San Román Del Barrio, Yahye MerhiAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4'-methylenebis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain exte
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, J. S. R. del Barrio, José Parra, Roi Rath, R. Vargas-coronado, Elizabeth Phelps, Jorge Cervantes, Alejandro Garcia, Yahye Merhi, Maryam TabrizianAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4'-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
Yahye Merhi - One of the best experts on this subject based on the ideXlab platform.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain extend
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, José Parra, Roi Rath, R. Vargas-coronado, José M. Cervantes-uc, Juan V. Cauich-rodríguez, Ea Phelps, Andrés J. García, J San Román Del Barrio, Yahye MerhiAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4'-methylenebis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain exte
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, J. S. R. del Barrio, José Parra, Roi Rath, R. Vargas-coronado, Elizabeth Phelps, Jorge Cervantes, Alejandro Garcia, Yahye Merhi, Maryam TabrizianAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4'-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
José Parra - One of the best experts on this subject based on the ideXlab platform.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain extend
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, José Parra, Roi Rath, R. Vargas-coronado, José M. Cervantes-uc, Juan V. Cauich-rodríguez, Ea Phelps, Andrés J. García, J San Román Del Barrio, Yahye MerhiAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4'-methylenebis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain exte
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, J. S. R. del Barrio, José Parra, Roi Rath, R. Vargas-coronado, Elizabeth Phelps, Jorge Cervantes, Alejandro Garcia, Yahye Merhi, Maryam TabrizianAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4'-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
Roi Rath - One of the best experts on this subject based on the ideXlab platform.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain extend
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, José Parra, Roi Rath, R. Vargas-coronado, José M. Cervantes-uc, Juan V. Cauich-rodríguez, Ea Phelps, Andrés J. García, J San Román Del Barrio, Yahye MerhiAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
-
Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4'-methylenebis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or Dithioerythritol as chain exte
Journal of Biomaterials Applications, 2012Co-Authors: L. Chan-Chan, J. S. R. del Barrio, José Parra, Roi Rath, R. Vargas-coronado, Elizabeth Phelps, Jorge Cervantes, Alejandro Garcia, Yahye Merhi, Maryam TabrizianAbstract:Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4'-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or Dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with Dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.